Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects.

Abstract

BACKGROUND:

A phospholipid, lysophosphatidylcholine (LPC), is the major determinant of the atherosclerotic properties of oxidized low-density lipoprotein (LDL). Under normal circumstances most LPC is bound to albumin. We hypothesized that lipoprotein LPC concentrations are increased in hypoalbuminemic patients with the nephrotic syndrome, irrespective of their lipid levels. To test this hypothesis, we selected nephrotic and control subjects with matched LDL cholesterol levels.

METHODS:

Lipoproteins and the albumin-rich lipoprotein-deficient fractions were separated by ultracentrifugation and their phospholipid composition was analyzed by thin-layer chromatography.

RESULTS:

Nephrotic subjects (albumin 23 +/- 2 g/liter and LDL cholesterol 3.1 +/- 0.2 mmol/liter) had a LDL LPC concentration that was increased (P < 0.05) to 66 +/- 7 vs. 35 +/- 6 micromol/liter in matched controls (albumin 42 +/- 5 g/liter and LDL cholesterol 3.1 +/- 0.2 mmol/liter). LPC in very low-density lipoprotein plus intermediate-density lipoprotein (VLDL + IDL) in these subjects was also increased to 33 +/- 7 vs. 9 +/- 2 micromol/liter in controls (P < 0.05). Conversely, LPC was decreased to 19 +/- 4 micromol/liter in the albumin-containing fraction of these hypoalbuminemic patients, as compared to 46 +/- 10 micromol/liter in the controls (P < 0.05). LPC was also low (14 +/- 4 micromol/liter) in the albumin-containing fraction of hypoalbuminemic, hypocholesterolemic patients with nonrenal diseases. In hyperlipidemic nephrotic subjects (albumin 21 +/- 2 g/liter and LDL cholesterol 5.7 +/- 0.5 mmol/liter) the LPC levels in LDL and VLDL + IDL were further increased, to 95 +/- 20 and 56 +/- 23 micromol/liter, respectively (P < 0.05).

CONCLUSION:

These findings suggest that in the presence of hypoalbuminemia in combination with proteinuria, LPC shifts from albumin to VLDL, IDL and LDL. This effect is independent of hyperlipidemia. Increased LPC in lipoproteins may be an important factor in the disproportionate increase in cardiovascular disease in nephrotic patients with hypoalbuminemia.

• Authors: T D Vuong, E S Stroes, N Willekes-Koolschijn, T J Rabelink, H A Koomans, J A Joles
• Journal: Kidney international (Kidney Int) Vol. 55 Issue 3 Pg. 1005-10 (Mar 1999) ISSN: 0085-2538 [Print] United States
• PMID: 10027937 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Lipoproteins
• Lipoproteins, IDL
• Lipoproteins, LDL
• Lipoproteins, VLDL
• Lysophosphatidylcholines
• Serum Albumin
• Cholesterol

Topics

• Adolescent
• Adult
• Aged
• Cardiovascular Diseases (etiology)
• Case-Control Studies
• Cholesterol (blood)
• Female
• Humans
• Hyperlipidemias (blood, complications)
• Lipoproteins (blood, chemistry)
• Lipoproteins, IDL
• Lipoproteins, LDL (blood, chemistry)
• Lipoproteins, VLDL (blood, chemistry)
• Lysophosphatidylcholines (blood)
• Male
• Middle Aged
• Nephrotic Syndrome (blood, complications)
• Protein Binding
• Serum Albumin (deficiency)